And this is an opportunity to kind of change that," Hamilton County Coroner Jeff Jellison said. "Because now we have coro ...

Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease (DKD) ...

Arbitrum co-founder Steven Goldfeder has ruled out the L2 becoming a based rollup and was circumspect about it becoming a ...

A leaked memo for grant management staff of the US government’s National Institutes of Health (NIH), dated March 25 and of ...

Gemini 2.5 Pro represents a significant step forward in AI model design, combining raw power with refined reasoning ...

AI bots from OpenAI and others consume massive bandwidth, affecting analytics and server resources for websites worldwide.

Preclinical Work Advancing with Plans to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the Clinic Later This ...

The District's goal is to create a collaborative environment for research and innovation, with close ties to USD to provide a ...

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for ...

Arpita Hajra is a preeminent technology leader based in Raleigh, NC, with more than 17 years of experience in software ...

"As a cancer patient, having options to manage the side effects of life saving drugs is very important. I believe the published results of crofelemer for the prophylaxis of CTD are very exciting and ...

Cliniphai launches Athena for clinical trial localization and translation technology designed for life sciences sector: Great Falls, Montana Thursday, March 27, 2025, 16:00 Hrs [I ...